Loss of the H3K27me3 signal is associated with the upregulation of several breast cancer oncogenes, such as those encoding epidermal growth factor receptor (EGFR) or insulin like growth factor binding protein 3 (IGFBP3) involved in tamoxifen resistance [178,179]. Here, EGFR is linked to breast carcinoma.